期刊文献+

Serum HBV RNA as a predictor of virological response in treatmentnaive chronic HBeAg-positive HBV-infected patients with normal alanine aminotransferase

原文传递
导出
摘要 According to current guidelines,patients with chronic hepatitis B virus(HBV)infection whose HBVDNA is positive but whose alanine aminotransferase(ALT)levels are normal do not currently need antiviral treatment, However,studies have found that even chronic HBV infection'patients withnormal ALTmay,progress to cirrhosis or hepatocellular carcinoma(HCC).Furthermore,almost half of patients with normal ALT levels were found to have moderate to severe inflammation and/or significant fibrosis[2]Currently there were only a few studies on the treatment of chronic HBV patients with normal ALT levels,and the factors that affect their virological response(VR)are still unclear.An increasing number of studies have proven that serum HBV RNAcan be used as a non-invasive indicator to predict a VR,i3i In this study,weexplored the predictivevalue of HBV RNA in anticipating a VR in normal ALTchronic HBV patients.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2022年第19期2351-2353,共3页 中华医学杂志(英文版)
基金 China Mega-Project for Infectious Diseases(Nos.2013ZX10002005 and 2017ZX10203202)。
  • 相关文献

参考文献1

二级参考文献29

共引文献271

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部